Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baxis Pharmaceuticals
Charlottesville, Virginia, United Statesdnb.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Baxis Pharmaceuticals is a private pharmaceutical company based in Charlottesville, Virginia. Its main focus is on infectious diseases and eye diseases. The company's lead asset is fusidic acid—a small molecule antibiotic—currently being developed for the treatment of bacterial conjunctivitis and previously indicated for skin infections. Fusidic acid has been approved internationally since the mid–1980s but remains investigational or at late-stage development under Baxis's portfolio for certain indications.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Baxis Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baxis Pharmaceuticals.